nodes	percent_of_prediction	percent_of_DWPC	metapath
Epirubicin—DHCR7—Vitamin D Metabolism—GC—chronic obstructive pulmonary disease	0.0364	0.232	CbGpPWpGaD
Epirubicin—CHD1—respiratory system—chronic obstructive pulmonary disease	0.0154	0.089	CbGeAlD
Epirubicin—CHD1—bronchus—chronic obstructive pulmonary disease	0.0127	0.0732	CbGeAlD
Epirubicin—CHD1—trachea—chronic obstructive pulmonary disease	0.0114	0.0657	CbGeAlD
Epirubicin—YWHAG—respiratory system—chronic obstructive pulmonary disease	0.00955	0.055	CbGeAlD
Epirubicin—DHCR7—bronchus—chronic obstructive pulmonary disease	0.00857	0.0494	CbGeAlD
Epirubicin—YWHAG—connective tissue—chronic obstructive pulmonary disease	0.00841	0.0484	CbGeAlD
Epirubicin—CHD1—lung—chronic obstructive pulmonary disease	0.0082	0.0472	CbGeAlD
Epirubicin—YWHAG—bronchus—chronic obstructive pulmonary disease	0.00786	0.0453	CbGeAlD
Epirubicin—DHCR7—trachea—chronic obstructive pulmonary disease	0.00769	0.0443	CbGeAlD
Epirubicin—YWHAG—smooth muscle tissue—chronic obstructive pulmonary disease	0.00769	0.0443	CbGeAlD
Epirubicin—PLA2G4A—Prostaglandin Synthesis and Regulation—SCGB1A1—chronic obstructive pulmonary disease	0.00738	0.0471	CbGpPWpGaD
Epirubicin—PLA2G4A—respiratory system—chronic obstructive pulmonary disease	0.00712	0.0411	CbGeAlD
Epirubicin—YWHAG—trachea—chronic obstructive pulmonary disease	0.00706	0.0407	CbGeAlD
Epirubicin—AURKA—lung—chronic obstructive pulmonary disease	0.00661	0.0381	CbGeAlD
Epirubicin—PLA2G4A—connective tissue—chronic obstructive pulmonary disease	0.00627	0.0361	CbGeAlD
Epirubicin—PLA2G4A—bronchus—chronic obstructive pulmonary disease	0.00586	0.0338	CbGeAlD
Epirubicin—PLA2G4A—smooth muscle tissue—chronic obstructive pulmonary disease	0.00574	0.0331	CbGeAlD
Epirubicin—TOP2A—bronchus—chronic obstructive pulmonary disease	0.00557	0.0321	CbGeAlD
Epirubicin—DHCR7—lung—chronic obstructive pulmonary disease	0.00553	0.0319	CbGeAlD
Epirubicin—PLA2G4A—trachea—chronic obstructive pulmonary disease	0.00526	0.0303	CbGeAlD
Epirubicin—YWHAG—lung—chronic obstructive pulmonary disease	0.00507	0.0292	CbGeAlD
Epirubicin—TOP2A—Salmeterol—Salbutamol—chronic obstructive pulmonary disease	0.00492	0.549	CbGdCrCtD
Epirubicin—Doxorubicin—NOS3—chronic obstructive pulmonary disease	0.00462	0.329	CrCbGaD
Epirubicin—Doxorubicin—NOS2—chronic obstructive pulmonary disease	0.00446	0.318	CrCbGaD
Epirubicin—PLA2G4A—lung—chronic obstructive pulmonary disease	0.00378	0.0218	CbGeAlD
Epirubicin—TOP2A—lung—chronic obstructive pulmonary disease	0.00359	0.0207	CbGeAlD
Epirubicin—UGT2B7—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00356	0.0227	CbGpPWpGaD
Epirubicin—ABCC1—bronchus—chronic obstructive pulmonary disease	0.00335	0.0193	CbGeAlD
Epirubicin—UGT2B7—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00315	0.0201	CbGpPWpGaD
Epirubicin—ABCC1—trachea—chronic obstructive pulmonary disease	0.00301	0.0174	CbGeAlD
Epirubicin—UGT2B7—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.00273	0.0174	CbGpPWpGaD
Epirubicin—UGT2B7—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00259	0.0165	CbGpPWpGaD
Epirubicin—Daunorubicin—CYP1A1—chronic obstructive pulmonary disease	0.00252	0.18	CrCbGaD
Epirubicin—Daunorubicin—CYP1A2—chronic obstructive pulmonary disease	0.00243	0.173	CrCbGaD
Epirubicin—PLA2G4A—p38 MAPK Signaling Pathway—TGFB2—chronic obstructive pulmonary disease	0.00237	0.0151	CbGpPWpGaD
Epirubicin—UGT2B7—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00229	0.0146	CbGpPWpGaD
Epirubicin—ABCC1—lung—chronic obstructive pulmonary disease	0.00216	0.0125	CbGeAlD
Epirubicin—YWHAG—a6b1 and a6b4 Integrin signaling—ERBB3—chronic obstructive pulmonary disease	0.00195	0.0125	CbGpPWpGaD
Epirubicin—PLA2G4A—Prostaglandin Synthesis and Regulation—EDN1—chronic obstructive pulmonary disease	0.0018	0.0115	CbGpPWpGaD
Epirubicin—PLA2G4A—Opioid Signalling—PDE4A—chronic obstructive pulmonary disease	0.0018	0.0115	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—HDAC2—chronic obstructive pulmonary disease	0.00177	0.0113	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—MMP14—chronic obstructive pulmonary disease	0.00171	0.0109	CbGpPWpGaD
Epirubicin—PLA2G4A—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00154	0.00985	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—HDAC2—chronic obstructive pulmonary disease	0.00146	0.0093	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.00143	0.00916	CbGpPWpGaD
Epirubicin—UGT2B7—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00139	0.00888	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.00138	0.00881	CbGpPWpGaD
Epirubicin—AURKA—Aurora A signaling—TP53—chronic obstructive pulmonary disease	0.00127	0.00809	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	0.00126	0.00802	CbGpPWpGaD
Epirubicin—ABCC1—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00123	0.00787	CbGpPWpGaD
Epirubicin—UGT2B7—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.00122	0.00778	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—NOS2—chronic obstructive pulmonary disease	0.00121	0.0077	CbGpPWpGaD
Epirubicin—UGT2B7—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.0012	0.00769	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.0012	0.00764	CbGpPWpGaD
Epirubicin—UGT2B7—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.00119	0.0076	CbGpPWpGaD
Epirubicin—YWHAG—Activation of BH3-only proteins—TP53—chronic obstructive pulmonary disease	0.00114	0.00728	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	0.00113	0.00724	CbGpPWpGaD
Epirubicin—PLA2G4A—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00112	0.00716	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.00106	0.00679	CbGpPWpGaD
Epirubicin—UGT2B7—Phase II conjugation—CYP1A2—chronic obstructive pulmonary disease	0.001	0.00639	CbGpPWpGaD
Epirubicin—PLA2G4A—Endothelins—EDN1—chronic obstructive pulmonary disease	0.000994	0.00635	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—APIP—chronic obstructive pulmonary disease	0.000991	0.00633	CbGpPWpGaD
Epirubicin—YWHAG—Calcium Regulation in the Cardiac Cell—ADRB2—chronic obstructive pulmonary disease	0.000922	0.00589	CbGpPWpGaD
Epirubicin—ABCC1—S1P1 pathway—VEGFA—chronic obstructive pulmonary disease	0.00091	0.00581	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—MMP1—chronic obstructive pulmonary disease	0.000904	0.00578	CbGpPWpGaD
Epirubicin—ABCC1—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000895	0.00572	CbGpPWpGaD
Epirubicin—UGT2B7—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.000868	0.00554	CbGpPWpGaD
Epirubicin—YWHAG—a6b1 and a6b4 Integrin signaling—EGFR—chronic obstructive pulmonary disease	0.000848	0.00542	CbGpPWpGaD
Epirubicin—PLA2G4A—Endothelins—MMP1—chronic obstructive pulmonary disease	0.000835	0.00534	CbGpPWpGaD
Epirubicin—UGT2B7—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	0.000835	0.00533	CbGpPWpGaD
Epirubicin—YWHAG—Intrinsic Pathway for Apoptosis—TP53—chronic obstructive pulmonary disease	0.000815	0.00521	CbGpPWpGaD
Epirubicin—TOP2A—Gastric Cancer Network 2—EGFR—chronic obstructive pulmonary disease	0.000799	0.00511	CbGpPWpGaD
Epirubicin—UGT2B7—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000794	0.00507	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	0.000785	0.00502	CbGpPWpGaD
Epirubicin—UGT2B7—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	0.000767	0.0049	CbGpPWpGaD
Epirubicin—UGT2B7—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000752	0.00481	CbGpPWpGaD
Epirubicin—YWHAG—LKB1 signaling events—TP53—chronic obstructive pulmonary disease	0.000739	0.00472	CbGpPWpGaD
Epirubicin—UGT2B7—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000738	0.00471	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—CXCL8—chronic obstructive pulmonary disease	0.000732	0.00468	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—NOS2—chronic obstructive pulmonary disease	0.000726	0.00464	CbGpPWpGaD
Epirubicin—PLA2G4A—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.000724	0.0809	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.000724	0.0809	CbGdCrCtD
Epirubicin—PLA2G4A—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.000707	0.079	CbGdCrCtD
Epirubicin—PLA2G4A—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.000707	0.079	CbGdCrCtD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000707	0.00451	CbGpPWpGaD
Epirubicin—UGT2B7—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000704	0.0045	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000702	0.00449	CbGpPWpGaD
Epirubicin—UGT2B7—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000696	0.00445	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	0.000695	0.00444	CbGpPWpGaD
Epirubicin—TOP2A—Gastric Cancer Network 2—TP53—chronic obstructive pulmonary disease	0.000671	0.00429	CbGpPWpGaD
Epirubicin—YWHAG—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—chronic obstructive pulmonary disease	0.000663	0.00423	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000657	0.00419	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000651	0.00416	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.000647	0.00413	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—GC—chronic obstructive pulmonary disease	0.000639	0.00408	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet homeostasis—NOS2—chronic obstructive pulmonary disease	0.000635	0.00406	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	0.000627	0.00401	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000626	0.004	CbGpPWpGaD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—NOS3—chronic obstructive pulmonary disease	0.00062	0.00396	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	0.000611	0.0039	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.000594	0.00379	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000594	0.00379	CbGpPWpGaD
Epirubicin—TOP2A—Methyltestosterone—Prednisone—chronic obstructive pulmonary disease	0.000594	0.0663	CbGdCrCtD
Epirubicin—TOP2A—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000592	0.00378	CbGpPWpGaD
Epirubicin—UGT2B7—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000585	0.00374	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—NOS3—chronic obstructive pulmonary disease	0.000584	0.00373	CbGpPWpGaD
Epirubicin—TOP2A—Methyltestosterone—Prednisolone—chronic obstructive pulmonary disease	0.000579	0.0647	CbGdCrCtD
Epirubicin—UGT2B7—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000577	0.00369	CbGpPWpGaD
Epirubicin—UGT2B7—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000557	0.00356	CbGpPWpGaD
Epirubicin—UGT2B7—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000549	0.00351	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	0.000548	0.0035	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	0.00053	0.00338	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling mediated by p38-alpha and p38-beta—TP53—chronic obstructive pulmonary disease	0.000528	0.00337	CbGpPWpGaD
Epirubicin—UGT2B7—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000511	0.00327	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet homeostasis—NOS3—chronic obstructive pulmonary disease	0.000511	0.00326	CbGpPWpGaD
Epirubicin—UGT2B7—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000488	0.00312	CbGpPWpGaD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—NOS3—chronic obstructive pulmonary disease	0.000486	0.00311	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000486	0.0031	CbGpPWpGaD
Epirubicin—UGT2B7—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000481	0.00308	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000473	0.00302	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000472	0.00302	CbGpPWpGaD
Epirubicin—PLA2G4A—AGE/RAGE pathway—MMP9—chronic obstructive pulmonary disease	0.000468	0.00299	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TGFB1—chronic obstructive pulmonary disease	0.00045	0.00287	CbGpPWpGaD
Epirubicin—UGT2B7—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000449	0.00287	CbGpPWpGaD
Epirubicin—UGT2B7—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000442	0.00283	CbGpPWpGaD
Epirubicin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000437	0.000675	CcSEcCtD
Epirubicin—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000435	0.000672	CcSEcCtD
Epirubicin—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000434	0.00067	CcSEcCtD
Epirubicin—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000433	0.000669	CcSEcCtD
Epirubicin—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000433	0.000669	CcSEcCtD
Epirubicin—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000432	0.000668	CcSEcCtD
Epirubicin—YWHAG—ErbB1 downstream signaling—EGFR—chronic obstructive pulmonary disease	0.000431	0.00275	CbGpPWpGaD
Epirubicin—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000429	0.000664	CcSEcCtD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	0.000429	0.00274	CbGpPWpGaD
Epirubicin—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000426	0.000659	CcSEcCtD
Epirubicin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000426	0.000659	CcSEcCtD
Epirubicin—UGT2B7—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000425	0.00272	CbGpPWpGaD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000425	0.00271	CbGpPWpGaD
Epirubicin—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000423	0.000654	CcSEcCtD
Epirubicin—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000422	0.000652	CcSEcCtD
Epirubicin—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000422	0.000652	CcSEcCtD
Epirubicin—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000421	0.000651	CcSEcCtD
Epirubicin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00042	0.000649	CcSEcCtD
Epirubicin—UGT2B7—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000419	0.00268	CbGpPWpGaD
Epirubicin—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000419	0.000648	CcSEcCtD
Epirubicin—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000418	0.000646	CcSEcCtD
Epirubicin—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000418	0.000645	CcSEcCtD
Epirubicin—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000416	0.000643	CcSEcCtD
Epirubicin—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000416	0.000642	CcSEcCtD
Epirubicin—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000414	0.00064	CcSEcCtD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—IL1B—chronic obstructive pulmonary disease	0.000414	0.00264	CbGpPWpGaD
Epirubicin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000412	0.000637	CcSEcCtD
Epirubicin—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000412	0.000637	CcSEcCtD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	0.000412	0.00263	CbGpPWpGaD
Epirubicin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000411	0.000636	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000411	0.000636	CcSEcCtD
Epirubicin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000408	0.000631	CcSEcCtD
Epirubicin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000408	0.000631	CcSEcCtD
Epirubicin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000406	0.000628	CcSEcCtD
Epirubicin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000406	0.000627	CcSEcCtD
Epirubicin—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000404	0.000624	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000403	0.000623	CcSEcCtD
Epirubicin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000402	0.000622	CcSEcCtD
Epirubicin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000402	0.000622	CcSEcCtD
Epirubicin—AURKA—EGF/EGFR Signaling Pathway—EGFR—chronic obstructive pulmonary disease	0.000402	0.00257	CbGpPWpGaD
Epirubicin—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000401	0.00062	CcSEcCtD
Epirubicin—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000401	0.00062	CcSEcCtD
Epirubicin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.0004	0.000618	CcSEcCtD
Epirubicin—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000399	0.000616	CcSEcCtD
Epirubicin—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000398	0.000616	CcSEcCtD
Epirubicin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000397	0.000614	CcSEcCtD
Epirubicin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000397	0.000614	CcSEcCtD
Epirubicin—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000397	0.000614	CcSEcCtD
Epirubicin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000396	0.000612	CcSEcCtD
Epirubicin—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000393	0.000608	CcSEcCtD
Epirubicin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000392	0.000606	CcSEcCtD
Epirubicin—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.000391	0.000605	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00039	0.000602	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00039	0.000602	CcSEcCtD
Epirubicin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000389	0.000602	CcSEcCtD
Epirubicin—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000389	0.000602	CcSEcCtD
Epirubicin—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000389	0.000602	CcSEcCtD
Epirubicin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000388	0.0006	CcSEcCtD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000388	0.00248	CbGpPWpGaD
Epirubicin—Pain—Formoterol—chronic obstructive pulmonary disease	0.000386	0.000597	CcSEcCtD
Epirubicin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000386	0.000597	CcSEcCtD
Epirubicin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000386	0.000597	CcSEcCtD
Epirubicin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000386	0.000597	CcSEcCtD
Epirubicin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000385	0.000596	CcSEcCtD
Epirubicin—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000385	0.000595	CcSEcCtD
Epirubicin—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000383	0.000592	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000382	0.00059	CcSEcCtD
Epirubicin—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000381	0.000589	CcSEcCtD
Epirubicin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00038	0.000587	CcSEcCtD
Epirubicin—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000379	0.000586	CcSEcCtD
Epirubicin—PLA2G4A—AGE/RAGE pathway—EGFR—chronic obstructive pulmonary disease	0.000378	0.00242	CbGpPWpGaD
Epirubicin—Pain—Montelukast—chronic obstructive pulmonary disease	0.000378	0.000584	CcSEcCtD
Epirubicin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000377	0.000583	CcSEcCtD
Epirubicin—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000376	0.000581	CcSEcCtD
Epirubicin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000375	0.00058	CcSEcCtD
Epirubicin—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000375	0.00058	CcSEcCtD
Epirubicin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000374	0.000578	CcSEcCtD
Epirubicin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000374	0.000577	CcSEcCtD
Epirubicin—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000373	0.000576	CcSEcCtD
Epirubicin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000372	0.000575	CcSEcCtD
Epirubicin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000372	0.000575	CcSEcCtD
Epirubicin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000372	0.000574	CcSEcCtD
Epirubicin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00037	0.000573	CcSEcCtD
Epirubicin—Cardiac failure—Prednisone—chronic obstructive pulmonary disease	0.00037	0.000572	CcSEcCtD
Epirubicin—YWHAG—Cell Cycle—TP53—chronic obstructive pulmonary disease	0.00037	0.00236	CbGpPWpGaD
Epirubicin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00037	0.000572	CcSEcCtD
Epirubicin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000369	0.000571	CcSEcCtD
Epirubicin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000369	0.000571	CcSEcCtD
Epirubicin—TOP2A—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000369	0.00236	CbGpPWpGaD
Epirubicin—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000369	0.00057	CcSEcCtD
Epirubicin—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000368	0.000569	CcSEcCtD
Epirubicin—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000367	0.000568	CcSEcCtD
Epirubicin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000364	0.000563	CcSEcCtD
Epirubicin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000364	0.000563	CcSEcCtD
Epirubicin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000362	0.000559	CcSEcCtD
Epirubicin—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000361	0.000559	CcSEcCtD
Epirubicin—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000361	0.000559	CcSEcCtD
Epirubicin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000359	0.000554	CcSEcCtD
Epirubicin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000359	0.000554	CcSEcCtD
Epirubicin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000357	0.000552	CcSEcCtD
Epirubicin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000357	0.000552	CcSEcCtD
Epirubicin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000357	0.000552	CcSEcCtD
Epirubicin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000357	0.000552	CcSEcCtD
Epirubicin—AURKA—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000357	0.00228	CbGpPWpGaD
Epirubicin—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.000356	0.00055	CcSEcCtD
Epirubicin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000356	0.00055	CcSEcCtD
Epirubicin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000353	0.000545	CcSEcCtD
Epirubicin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000352	0.000545	CcSEcCtD
Epirubicin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000352	0.000545	CcSEcCtD
Epirubicin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000351	0.000543	CcSEcCtD
Epirubicin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000351	0.000543	CcSEcCtD
Epirubicin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00035	0.000542	CcSEcCtD
Epirubicin—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.00035	0.000541	CcSEcCtD
Epirubicin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00035	0.00054	CcSEcCtD
Epirubicin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00035	0.00054	CcSEcCtD
Epirubicin—DHCR7—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000349	0.00223	CbGpPWpGaD
Epirubicin—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000349	0.000539	CcSEcCtD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	0.000349	0.00223	CbGpPWpGaD
Epirubicin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000349	0.000539	CcSEcCtD
Epirubicin—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000346	0.000535	CcSEcCtD
Epirubicin—DHCR7—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000345	0.0022	CbGpPWpGaD
Epirubicin—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000344	0.000532	CcSEcCtD
Epirubicin—TOP2A—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000344	0.0022	CbGpPWpGaD
Epirubicin—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.000344	0.000531	CcSEcCtD
Epirubicin—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000342	0.000529	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—APIP—chronic obstructive pulmonary disease	0.000342	0.00219	CbGpPWpGaD
Epirubicin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000339	0.000523	CcSEcCtD
Epirubicin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000337	0.000521	CcSEcCtD
Epirubicin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000337	0.000521	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—APIP—chronic obstructive pulmonary disease	0.000336	0.00214	CbGpPWpGaD
Epirubicin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000333	0.000514	CcSEcCtD
Epirubicin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000333	0.000514	CcSEcCtD
Epirubicin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000332	0.000514	CcSEcCtD
Epirubicin—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000332	0.000513	CcSEcCtD
Epirubicin—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000331	0.000512	CcSEcCtD
Epirubicin—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000329	0.000508	CcSEcCtD
Epirubicin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000326	0.000503	CcSEcCtD
Epirubicin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000324	0.000501	CcSEcCtD
Epirubicin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000324	0.000501	CcSEcCtD
Epirubicin—DHCR7—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000322	0.00205	CbGpPWpGaD
Epirubicin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000319	0.000494	CcSEcCtD
Epirubicin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000319	0.000494	CcSEcCtD
Epirubicin—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.000319	0.000493	CcSEcCtD
Epirubicin—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000319	0.000493	CcSEcCtD
Epirubicin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000317	0.00049	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	0.000315	0.00201	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000315	0.00201	CbGpPWpGaD
Epirubicin—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000314	0.000486	CcSEcCtD
Epirubicin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000314	0.000485	CcSEcCtD
Epirubicin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000313	0.000483	CcSEcCtD
Epirubicin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000309	0.000477	CcSEcCtD
Epirubicin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000309	0.000477	CcSEcCtD
Epirubicin—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000307	0.000475	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000307	0.00196	CbGpPWpGaD
Epirubicin—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000306	0.000473	CcSEcCtD
Epirubicin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000306	0.000473	CcSEcCtD
Epirubicin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000302	0.000468	CcSEcCtD
Epirubicin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000302	0.000466	CcSEcCtD
Epirubicin—YWHAG—Apoptosis—TNF—chronic obstructive pulmonary disease	0.0003	0.00192	CbGpPWpGaD
Epirubicin—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.0003	0.000463	CcSEcCtD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	0.000299	0.00191	CbGpPWpGaD
Epirubicin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000298	0.000461	CcSEcCtD
Epirubicin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000298	0.000461	CcSEcCtD
Epirubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—chronic obstructive pulmonary disease	0.000294	0.00188	CbGpPWpGaD
Epirubicin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000292	0.000452	CcSEcCtD
Epirubicin—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000292	0.000451	CcSEcCtD
Epirubicin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.000451	CcSEcCtD
Epirubicin—DHCR7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00029	0.00185	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000289	0.00185	CbGpPWpGaD
Epirubicin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000287	0.000444	CcSEcCtD
Epirubicin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000287	0.000444	CcSEcCtD
Epirubicin—Rash—Formoterol—chronic obstructive pulmonary disease	0.000285	0.00044	CcSEcCtD
Epirubicin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000285	0.00044	CcSEcCtD
Epirubicin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000284	0.00044	CcSEcCtD
Epirubicin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000284	0.00044	CcSEcCtD
Epirubicin—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000284	0.000439	CcSEcCtD
Epirubicin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000283	0.000437	CcSEcCtD
Epirubicin—Headache—Formoterol—chronic obstructive pulmonary disease	0.000283	0.000437	CcSEcCtD
Epirubicin—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000283	0.000437	CcSEcCtD
Epirubicin—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000282	0.000436	CcSEcCtD
Epirubicin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000282	0.000436	CcSEcCtD
Epirubicin—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000282	0.000436	CcSEcCtD
Epirubicin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000281	0.000435	CcSEcCtD
Epirubicin—Rash—Montelukast—chronic obstructive pulmonary disease	0.000279	0.000431	CcSEcCtD
Epirubicin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000279	0.00043	CcSEcCtD
Epirubicin—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000278	0.00043	CcSEcCtD
Epirubicin—Headache—Montelukast—chronic obstructive pulmonary disease	0.000277	0.000428	CcSEcCtD
Epirubicin—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000273	0.000422	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—TGFB2—chronic obstructive pulmonary disease	0.000273	0.00174	CbGpPWpGaD
Epirubicin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000271	0.000419	CcSEcCtD
Epirubicin—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.00027	0.000418	CcSEcCtD
Epirubicin—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000269	0.000416	CcSEcCtD
Epirubicin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000269	0.000415	CcSEcCtD
Epirubicin—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000269	0.000415	CcSEcCtD
Epirubicin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000268	0.000415	CcSEcCtD
Epirubicin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000268	0.000414	CcSEcCtD
Epirubicin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000268	0.000414	CcSEcCtD
Epirubicin—ABCC1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000268	0.00171	CbGpPWpGaD
Epirubicin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000267	0.000413	CcSEcCtD
Epirubicin—YWHAG—Apoptosis—TP53—chronic obstructive pulmonary disease	0.000265	0.00169	CbGpPWpGaD
Epirubicin—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000263	0.000407	CcSEcCtD
Epirubicin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000263	0.000406	CcSEcCtD
Epirubicin—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.00026	0.000401	CcSEcCtD
Epirubicin—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000259	0.0004	CcSEcCtD
Epirubicin—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000255	0.000393	CcSEcCtD
Epirubicin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000253	0.000391	CcSEcCtD
Epirubicin—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000252	0.000389	CcSEcCtD
Epirubicin—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000251	0.000388	CcSEcCtD
Epirubicin—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.00025	0.000386	CcSEcCtD
Epirubicin—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000246	0.00038	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—HDAC2—chronic obstructive pulmonary disease	0.000245	0.00156	CbGpPWpGaD
Epirubicin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000244	0.000378	CcSEcCtD
Epirubicin—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000244	0.000378	CcSEcCtD
Epirubicin—YWHAG—Myometrial Relaxation and Contraction Pathways—IL6—chronic obstructive pulmonary disease	0.000242	0.00155	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000242	0.00155	CbGpPWpGaD
Epirubicin—YWHAG—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	0.000241	0.00154	CbGpPWpGaD
Epirubicin—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000241	0.000372	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000239	0.00153	CbGpPWpGaD
Epirubicin—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000239	0.000369	CcSEcCtD
Epirubicin—DHCR7—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000239	0.00152	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000238	0.00152	CbGpPWpGaD
Epirubicin—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000236	0.000365	CcSEcCtD
Epirubicin—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000234	0.000361	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	0.000232	0.00148	CbGpPWpGaD
Epirubicin—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000232	0.000359	CcSEcCtD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—ALB—chronic obstructive pulmonary disease	0.000232	0.00148	CbGpPWpGaD
Epirubicin—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000227	0.000351	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000227	0.00145	CbGpPWpGaD
Epirubicin—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000226	0.000349	CcSEcCtD
Epirubicin—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000223	0.000345	CcSEcCtD
Epirubicin—DHCR7—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000222	0.00142	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000222	0.00142	CbGpPWpGaD
Epirubicin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000221	0.000342	CcSEcCtD
Epirubicin—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000221	0.000342	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—PLAUR—chronic obstructive pulmonary disease	0.000221	0.00141	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GC—chronic obstructive pulmonary disease	0.00022	0.00141	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.00022	0.00141	CbGpPWpGaD
Epirubicin—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.00022	0.000339	CcSEcCtD
Epirubicin—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000219	0.000339	CcSEcCtD
Epirubicin—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000218	0.000336	CcSEcCtD
Epirubicin—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000218	0.000336	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—GC—chronic obstructive pulmonary disease	0.000216	0.00138	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000211	0.00135	CbGpPWpGaD
Epirubicin—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.000323	CcSEcCtD
Epirubicin—UGT2B7—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000208	0.00133	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.000207	0.00132	CbGpPWpGaD
Epirubicin—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000205	0.000317	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000205	0.00131	CbGpPWpGaD
Epirubicin—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000202	0.000312	CcSEcCtD
Epirubicin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000201	0.000311	CcSEcCtD
Epirubicin—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000201	0.000311	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000201	0.00128	CbGpPWpGaD
Epirubicin—Agitation—Prednisone—chronic obstructive pulmonary disease	0.0002	0.000309	CcSEcCtD
Epirubicin—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000196	0.000303	CcSEcCtD
Epirubicin—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000196	0.000302	CcSEcCtD
Epirubicin—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000195	0.000302	CcSEcCtD
Epirubicin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000194	0.0003	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000192	0.00123	CbGpPWpGaD
Epirubicin—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000191	0.000296	CcSEcCtD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000191	0.00122	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.00019	0.00122	CbGpPWpGaD
Epirubicin—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000189	0.000291	CcSEcCtD
Epirubicin—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000188	0.00029	CcSEcCtD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000187	0.00119	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000186	0.00119	CbGpPWpGaD
Epirubicin—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000185	0.000286	CcSEcCtD
Epirubicin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000185	0.000286	CcSEcCtD
Epirubicin—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000185	0.000285	CcSEcCtD
Epirubicin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000184	0.000284	CcSEcCtD
Epirubicin—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000183	0.000283	CcSEcCtD
Epirubicin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00018	0.000278	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	0.00018	0.00115	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000178	0.00114	CbGpPWpGaD
Epirubicin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000178	0.000275	CcSEcCtD
Epirubicin—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000178	0.000275	CcSEcCtD
Epirubicin—ABCC1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000178	0.00113	CbGpPWpGaD
Epirubicin—Infection—Prednisone—chronic obstructive pulmonary disease	0.000176	0.000273	CcSEcCtD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000176	0.00113	CbGpPWpGaD
Epirubicin—Shock—Prednisone—chronic obstructive pulmonary disease	0.000175	0.00027	CcSEcCtD
Epirubicin—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000174	0.000269	CcSEcCtD
Epirubicin—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000268	CcSEcCtD
Epirubicin—ABCC1—Metabolism—GC—chronic obstructive pulmonary disease	0.000173	0.0011	CbGpPWpGaD
Epirubicin—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000267	CcSEcCtD
Epirubicin—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000172	0.000265	CcSEcCtD
Epirubicin—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000169	0.000262	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	0.000165	0.00105	CbGpPWpGaD
Epirubicin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000162	0.00025	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	0.000162	0.00103	CbGpPWpGaD
Epirubicin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000162	0.00025	CcSEcCtD
Epirubicin—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000161	0.000248	CcSEcCtD
Epirubicin—ABCC1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000161	0.00103	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.00016	0.00102	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	0.00016	0.00102	CbGpPWpGaD
Epirubicin—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.00016	0.000247	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—MMP1—chronic obstructive pulmonary disease	0.000158	0.00101	CbGpPWpGaD
Epirubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000157	0.001	CbGpPWpGaD
Epirubicin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000156	0.000242	CcSEcCtD
Epirubicin—PLA2G4A—Hemostasis—PLAU—chronic obstructive pulmonary disease	0.000155	0.000989	CbGpPWpGaD
Epirubicin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000154	0.000239	CcSEcCtD
Epirubicin—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.000238	CcSEcCtD
Epirubicin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000154	0.000238	CcSEcCtD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	0.000154	0.000984	CbGpPWpGaD
Epirubicin—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000153	0.000237	CcSEcCtD
Epirubicin—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000153	0.000237	CcSEcCtD
Epirubicin—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000235	CcSEcCtD
Epirubicin—TOP2A—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	0.00015	0.000961	CbGpPWpGaD
Epirubicin—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	0.000147	0.000937	CbGpPWpGaD
Epirubicin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000146	0.000226	CcSEcCtD
Epirubicin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000225	CcSEcCtD
Epirubicin—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000145	0.000224	CcSEcCtD
Epirubicin—DHCR7—Metabolism—ALB—chronic obstructive pulmonary disease	0.000143	0.000915	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—NOS2—chronic obstructive pulmonary disease	0.000142	0.000909	CbGpPWpGaD
Epirubicin—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000218	CcSEcCtD
Epirubicin—PLA2G4A—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000141	0.0009	CbGpPWpGaD
Epirubicin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000217	CcSEcCtD
Epirubicin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00014	0.000217	CcSEcCtD
Epirubicin—ABCC1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000138	0.00088	CbGpPWpGaD
Epirubicin—TOP2A—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	0.000138	0.00088	CbGpPWpGaD
Epirubicin—DHCR7—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000137	0.000875	CbGpPWpGaD
Epirubicin—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	0.000136	0.000867	CbGpPWpGaD
Epirubicin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000202	CcSEcCtD
Epirubicin—AURKA—Cell Cycle—TP53—chronic obstructive pulmonary disease	0.000128	0.000818	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000128	0.000817	CbGpPWpGaD
Epirubicin—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000197	CcSEcCtD
Epirubicin—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000194	CcSEcCtD
Epirubicin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000188	CcSEcCtD
Epirubicin—PLA2G4A—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000121	0.00077	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.00012	0.000769	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	0.00012	0.000765	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—ALB—chronic obstructive pulmonary disease	0.00012	0.000764	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000119	0.000761	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000118	0.000755	CbGpPWpGaD
Epirubicin—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000117	0.000182	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000117	0.000746	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—NOS3—chronic obstructive pulmonary disease	0.000114	0.000731	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000114	0.000725	CbGpPWpGaD
Epirubicin—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000113	0.000175	CcSEcCtD
Epirubicin—Rash—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000173	CcSEcCtD
Epirubicin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000112	0.000173	CcSEcCtD
Epirubicin—Headache—Prednisone—chronic obstructive pulmonary disease	0.000111	0.000172	CcSEcCtD
Epirubicin—PLA2G4A—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000109	0.000695	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000109	0.000694	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000108	0.000688	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000107	0.000681	CbGpPWpGaD
Epirubicin—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000106	0.000163	CcSEcCtD
Epirubicin—UGT2B7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.0001	0.000639	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.82e-05	0.000627	CbGpPWpGaD
Epirubicin—YWHAG—Cell Cycle—TP53—chronic obstructive pulmonary disease	9.7e-05	0.00062	CbGpPWpGaD
Epirubicin—ABCC1—Disease—HDAC2—chronic obstructive pulmonary disease	9.47e-05	0.000605	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTT1—chronic obstructive pulmonary disease	9.44e-05	0.000603	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	9.43e-05	0.000602	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GCLC—chronic obstructive pulmonary disease	9.33e-05	0.000596	CbGpPWpGaD
Epirubicin—ABCC1—Disease—KL—chronic obstructive pulmonary disease	8.81e-05	0.000563	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	8.7e-05	0.000556	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CTGF—chronic obstructive pulmonary disease	8.51e-05	0.000544	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.35e-05	0.000533	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	8.3e-05	0.00053	CbGpPWpGaD
Epirubicin—ABCC1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.27e-05	0.000528	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—VEGFA—chronic obstructive pulmonary disease	8.24e-05	0.000526	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.23e-05	0.000526	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.19e-05	0.000523	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.07e-05	0.000516	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.84e-05	0.000501	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.72e-05	0.000493	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.67e-05	0.00049	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TGFB1—chronic obstructive pulmonary disease	7.56e-05	0.000483	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.52e-05	0.000481	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.27e-05	0.000465	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.13e-05	0.000456	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	7.12e-05	0.000455	CbGpPWpGaD
Epirubicin—TOP2A—Cell Cycle—TP53—chronic obstructive pulmonary disease	6.78e-05	0.000433	CbGpPWpGaD
Epirubicin—ABCC1—Disease—ERBB3—chronic obstructive pulmonary disease	6.6e-05	0.000422	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.54e-05	0.000418	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.45e-05	0.000412	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.36e-05	0.000407	CbGpPWpGaD
Epirubicin—PLA2G4A—Hemostasis—TP53—chronic obstructive pulmonary disease	6.23e-05	0.000398	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.01e-05	0.000384	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.82e-05	0.000372	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.79e-05	0.00037	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.7e-05	0.000364	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.57e-05	0.000356	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOS2—chronic obstructive pulmonary disease	5.5e-05	0.000352	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.18e-05	0.000331	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—ALB—chronic obstructive pulmonary disease	4.94e-05	0.000316	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—ALB—chronic obstructive pulmonary disease	4.85e-05	0.00031	CbGpPWpGaD
Epirubicin—UGT2B7—Metabolism—NOS3—chronic obstructive pulmonary disease	4.73e-05	0.000302	CbGpPWpGaD
Epirubicin—PLA2G4A—Metabolism—NOS3—chronic obstructive pulmonary disease	4.64e-05	0.000296	CbGpPWpGaD
Epirubicin—ABCC1—Disease—SERPINE1—chronic obstructive pulmonary disease	4.63e-05	0.000296	CbGpPWpGaD
Epirubicin—ABCC1—Disease—NOS3—chronic obstructive pulmonary disease	4.42e-05	0.000283	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.26e-05	0.000272	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	4.06e-05	0.000259	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.88e-05	0.000248	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—ALB—chronic obstructive pulmonary disease	3.87e-05	0.000247	CbGpPWpGaD
Epirubicin—ABCC1—Metabolism—NOS3—chronic obstructive pulmonary disease	3.71e-05	0.000237	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.44e-05	0.00022	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.27e-05	0.000209	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.11e-05	0.000199	CbGpPWpGaD
Epirubicin—ABCC1—Disease—TGFB1—chronic obstructive pulmonary disease	2.93e-05	0.000187	CbGpPWpGaD
Epirubicin—ABCC1—Disease—EGFR—chronic obstructive pulmonary disease	2.87e-05	0.000183	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.79e-05	0.000178	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.56e-05	0.000164	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.51e-05	0.000161	CbGpPWpGaD
Epirubicin—ABCC1—Disease—IL6—chronic obstructive pulmonary disease	2.2e-05	0.000141	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.11e-05	0.000135	CbGpPWpGaD
Epirubicin—PLA2G4A—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.93e-05	0.000123	CbGpPWpGaD
